SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Orchid Pharma informs about newspaper advertisements

28 Oct 2023 Evaluate

In continuation to earlier announcements dated October 23, 2023, Orchid Pharma has informed that it enclosed copies of newspaper advertisements published in Financial Express (All India Edition - English) and Makkal Kural (Vernacular Language - Tamil) on October 28, 2023, regarding the Notice of the Postal Ballot of the Company including Cut-off date, Remote e-Voting information in accordance to Section 110 and 108 of the Companies Act, 2013 read with Rule 20 of Companies (Management and Administration) Rules, 2014 (as amended) and SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Copy of the Newspaper Advertisement is also available on the website of the Company at www.orchidpharma.com

The above information is a part of company’s filings submitted to BSE.

Orchid Pharma Share Price

564.10 -3.40 (-0.60%)
16-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1693.15
Dr. Reddys Lab 1221.25
Cipla 1230.75
Zydus Lifesciences 939.20
Lupin 2326.50
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×